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Tuberculosis of the central nervous system (CNS-TB) is a devastating complication of 
tuberculosis, and tumor necrosis factor (TNF) is crucial for innate immunity and con-
trolling the infection. TNF is produced by many cell types upon activation, in particularly 
the myeloid and T cells during neuroinflammation. Here we used mice with TNF ablation 
targeted to myeloid and T cell (MT-TNF−/−) to assess the contribution of myeloid and T 
cell-derived TNF in immune responses during CNS-TB. These mice exhibited impaired 
innate immunity and high susceptibility to cerebral Mycobacterium tuberculosis infection, 
a similar phenotype to complete TNF-deficient mice. Further, MT-TNF−/− mice were not 
able to control T cell responses and cytokine/chemokine production. Thus, our data 
suggested that collective TNF production by both myeloid and T cells are required to 
provide overall protective immunity against CNS-TB infection.
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inTrODUcTiOn
Tumor necrosis factor (TNF) is a pleiotropic cytokine involved in protective cell-mediated immunity 
against mycobacterial infection. In humans, primates and mice, TNF is shown to be essential for the 
maintenance of granuloma structures and for effective control of pulmonary mycobacterial replica-
tion (1–4). Mutation of the leukotriene A4 hydrolase locus, which controls the balance of pro- and 
anti-inflammatory eicosanoids, showed two distinct molecular routes to mycobacterial susceptibility 
converging on dysregulated levels of TNF (5, 6).
Tuberculosis of the central nervous system (CNS-TB) is a severe form of extrapulmonary 
tuberculosis, generally caused by hematogenous dissemination of Mycobacterium tuberculosis (M. 
tuberculosis) after primary lung infection (7, 8). Earlier animal models of CNS-TB enabled investiga-
tion of therapeutic strategies and understanding of immune regulation during CNS-TB despite the 
limitation in the route of pathogen entry to the CNS (9–11). In animal studies, similar cytokine 
profile was observed as in CNS-TB patients (12, 13), and the genetic deficiencies of immune effectors 
such as TNF and iNOS have confirmed its importance as critical for immune protection against 
tuberculosis in the CNS (14, 15).
Homeostasis is crucial for neural activities; therefore, the interactions between the CNS and 
immune systems must be tightly regulated to maintain balance between immune and neural func-
tions. This is supported by the blood–brain barrier which separates the CNS from the regular systemic 
blood circulation that protects the CNS from the milieu of the periphery. However, research findings 
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have demonstrated that both resident and infiltrating immune 
cells participate actively in immune responses in the CNS, which 
upon activation may secrete cytokines including TNF (16–20). 
Also, using animal models of TNF deficient or overexpression, 
we and others have directly demonstrated the important role of 
TNF in pathogenesis and protective immunity during CNS-TB 
infection (15, 21).
In the brain, TNF is synthesized by both immune (including 
infiltrating cells) and non-immune cells (including neurons). 
Microglial cells, as the resident immune cells of the CNS, are 
thought to be the first line of defense and main source of TNF 
during CNS-TB (18, 22–24). The peripheral T cells have the 
ability to produce TNF along with interferon-γ (IFN-γ) that acts 
in both innate and specific cell-mediated immunities during 
mycobacterial infection (25–27). Moreover, intracerebral BCG 
infection induces infiltration of IFN-γ and TNF producing T 
cells into the CNS (18, 28). In a previous study, we reported 
on the prominence of TNF-mediated innate immunity during 
cerebral tuberculosis while neuron-derived TNF was found to 
be dispensable (15). Therefore, further identifying the cellular 
sources of TNF that contribute to the pathogenesis and immu-
nity in the context of CNS-TB is of significant interest. In this 
study we investigated the functions of TNF produced collectively 
by myeloid and T cells in mediating immune protection against 
cerebral M. tuberculosis infection. We used mice deficient 
for both myeloid- and T cell-derived TNF (MT-TNF−/−) and 
investigated outcomes after intracerebral M. tuberculosis infec-
tion in comparative studies with TNF floxed wild-type (TNFf/f) 
and complete TNF-deficient (TNF−/−) mice. We demonstrate 
the significance of TNF production by myeloid and T cells for 
controlling CNS-TB infection.
MaTerials anD MeThODs
Mice
All mouse strains, including TNF floxed wild type (TNFf/f), 
myeloid TNF deficient (MN-TNF−/−), T-cell TNF deficient 
(T-TNF−/−), myeloid and T-cell TNF deficient (MT-TNF−/−), 
and complete TNF deficient (TNF−/−) were previously described 
(4, 15, 19, 29) and maintained under specific pathogen-free con-
ditions at the research animal facility of the University of Cape 
Town. Adult mice were PCR genotyped and used between 6 and 
12 weeks of age. Infected mice were maintained under biosafety 
level 3 conditions. All animal procedures were approved by the 
Animal Research Ethics Committee, University of Cape Town, in 
accordance with the South African National Standard.
intracerebral infection
Mycobacterium tuberculosis strain H37Rv was grown at 37°C 
in Middlebrook 7H9 broth containing 10% OADC and 0.5% 
Tween-80 until log phase, then aliquoted and stored at −80°C. 
A frozen aliquot was thawed, passed 30 times through 29 gauge 
needle and diluted in sterile saline. Intracerebral infection was 
performed using a stereotaxic approach of directly injecting 
H37Rv into the cerebral cortex. Prior to inoculation, a small 
burr hole was constructed anterior to the bregma and to the left 
of the midline in the skull exposing the dura mater. Mice were 
inoculated intracerebrally with 1 × 104–1 × 105 colony forming 
units (CFUs) of M. tuberculosis H37Rv using Hamilton syringe 
(Gastight no. 1701, Switzerland). The burr hole was sealed with 
bone wax and the skin sutured.
colony enumeration assay
Bacterial burdens in the brains, lungs, and spleens of infected 
mice were determined at specific time points after infection 
with M. tuberculosis. Organs were weighed and homogenized 
in 0.04% Tween 80 saline. Also, 10-fold serial dilutions of organ 
homogenates were plated in duplicates on Middlebrook 7H10 
(Becton, Dickinson and Company) agar containing 10% OADC 
(Life Technologies, Gaitherburg, MD, USA), and incubated at 
37°C for 19–21 days. The concentration of M. tuberculosis was 
then determined by counting the CFUs.
Flow cytometry
Mouse brains were collected to generate single cell suspensions. 
Non-specific binding to cells was blocked through incuba-
tion with αFcγRIII (1  mg/ml of rat α-mouse CD32/16c). The 
following antibodies were used to stain the surface markers: 
CD11b-PerCP-Cy5-5 (Clone M1/70), CD11c-Alexa 700 (Clone 
HL3), CD45-APC (Clone 30- F11), CD80-FITC (16–10  A1), 
CD86-V450 (Clone GL1), MHCII/(I-A/I-E)-PE (M5/114.15.2), 
CD3?-Pacific Blue, CD4-Alexa 700, and CD8-PerCP-Cy5.5. All 
antibodies were from BD Pharmingen™ and BD Horizon™. 
After staining, cells were washed and fixed, then analyzed on 
BD LSR Fortessa (Beckton Dickinson) flow cytometer using Cell 
Quest software.
Quantification of chemokines and 
cytokines
Supernatants from brain homogenates were prepared for cytokine 
and chemokine measurement by enzyme-linked immunosorbent 
assay (ELISA) after 3 weeks subsequent to intracerebral M. tuber-
culosis infection. The chemokines MCP-1, MIP-1α, and RANTES; 
and the cytokines IFN-γ, IL-2, IL-6, IL-12p70, and TNF (R&D 
Systems, Germany) were measured using commercially available 
ELISA reagents according to the manufacturer’s instructions. 
Chemokine and cytokine concentrations were measured by 
absorbance using a Versamax Microplate Reader (Molecular 
Devices, LLC, CA, USA) with SoftMax software.
statistical analysis
The data are presented as the mean ± SEM. Statistical analysis was 
performed by two-way ANOVA and one-tailed t-test. For all tests, 
a p-value of ≤0.05 was considered significant.
resUlTs
TnF Produced by Myeloid cell and T-cell 
are required for Protection against  
M. tuberculosis infection in the Brain 
(similar to TnF−/−)
Myeloid and T-cells contribute significantly to the pathogenesis 
of pulmonary tuberculosis (4, 30). To address the contribution 
TaBle 1 | clinical parameters of cerebral tuberculosis in various cell-
specific tumor necrosis factor (TnF)-deficient mice.
Day 25 Day 105
Mortality (%) Body weight 
change (%)
Mortality (%) Body weight 
change (%)
TNFf/f 0 (0/27) 2.8 0 (0/27) 4.6
MN-TNF−/− 0 (0/20) 1.9 0 (0/20) 2.9
T-TNF−/− 0 (0/22) 1.3 4.5 (1/22) 3.4
MT-TNF−/− 94.1 (16/17) −26.8 – –
TNF−/− 91.7 (22/24) −21.4 – –
The data are pooled of at least three independent experiments.
3
Hsu et al. Cell-Specific TNF and CNS-TB
Frontiers in Immunology | www.frontiersin.org February 2017 | Volume 8 | Article 180
of TNF derived from myeloid and T cells in protective immunity 
against CNS-TB, we intracerebrally challenged the mice with 
M. tuberculosis and compared disease progression in various 
cell-specific TNF-deficient mice, including myeloid specific 
(MN-TNF−/−), T-cell specific (T-TNF−/−), and TNF deficient in 
both myeloid and T-cells (MT-TNF−/−). We found that MN-TNF−/− 
and T-TNF−/− mice survived the infection similar to wild-type 
TNFf/f mice (Table 1); therefore, TNF deficiency in either myeloid 
cells or T cells had no effects on the overall protection against cer-
ebral tuberculosis. Interestingly, the MT-TNF−/− mice succumbed 
to the infection similar to the complete-deficient TNF−/− mice 
(Table  1; Figures  1A,B). As previously reported (15), TNF−/− 
mice were highly susceptible to cerebral M. tuberculosis infection 
resulting in rapid weight loss and death by 3 weeks postinfection. 
In comparison to TNF−/− mice, MT-TNF−/− mice were similarly 
highly susceptible and rapidly succumbed to infection with >20% 
body weight loss (Figures 1A,B).
To further investigate the synergistic role of myeloid and 
T-cell-derived TNF to control cerebral bacilli replication, we 
assessed bacterial burden in the brains of M. tuberculosis infected 
TNFf/f, MT-TNF−/−, and TNF−/− mice (Figure 1C). MT-TNF−/− 
and TNF−/− mice exhibited similar significant increases in 
cerebral bacilli burdens compared to TNFf/f mice at day 14 
(p < 0.001) and day 21 (p < 0.01) postinfection. We next assessed 
the extent of dissemination of bacilli from the brain by measuring 
the levels of pulmonary and splenic bacterial burden (Figure 1C). 
MT-TNF−/− mice showed mycobacterial dissemination similar to 
the TNF−/− mice in both lungs and spleens which were 1–2 log10 
higher than TNFf/f wild-type mice. Thus, these data demonstrate 
that myeloid and T cell-derived TNF is a collective requirement 
for cerebral immune protection and control of M. tuberculosis 
replication.
Myeloid cell and T-cell-Derived TnF are 
essential to control Pathology and 
inflammation during cerebral Tuberculosis
We next examined the synergistic role of myeloid and T-cell-
derived TNF to control cerebral inflammation by analysis of 
brain histopathology in M. tuberculosis-infected mice at 3 weeks 
postinfection (Figure 2). In the brain sections taken from TNFf/f 
and TNF−/− mice, we observed similar degrees of inflammation 
as to what we reported previously (15). The cerebral inflamma-
tion was controlled in TNFf/f mice, suggested by the predominant 
lymphocytic infiltration found in the choroid plexus and ventricles 
of TNFf/f brains. In contrast, both MT-TNF−/− and TNF−/− mice 
exhibited severe neuropathology and uncontrolled inflammation 
where cellular infiltration was extended to the periventricular 
tissue. Similar to TNF−/− mice, MT-TNF−/− mice also had foci 
of necrosis in the brain tissue where acid fast bacilli were largely 
found.
The neuropathology observed in the MT-TNF−/− mice sug-
gested defective TNF-mediated cellular recruitment and innate 
immune responses in response to M. tuberculosis challenge. 
We, therefore, quantified microglia (CD11b+CD45low) and mac-
rophages (CD11b+CD45high) in the brain and evaluated activa-
tion status of these innate immune cells subsequent to 3 weeks 
cerebral M. tuberculosis infection. The flowcytometric analysis 
revealed significantly higher (p < 0.05) frequencies and absolute 
cell numbers of microglia and macrophages in both TNF−/− and 
MT-TNF−/− mice (Figure 3). To investigate the capacity of micro-
glia and macrophages to present antigen and activate lympho-
cytes, we analyzed the expression of MHCII, CD80, and CD86. 
Apart from similar levels of CD86 in all three mouse strains (data 
not shown), we observed significantly lower (p < 0.01) expression 
of CD80 and MHCII in MT-TNF−/− compared to TNFf/f mice 
(Figure 3).
Therefore, myeloid cell and T-cell-derived TNF were required 
to regulate CNS inflammation during M. tuberculosis infec-
tion; moreover, it determined the quality of the innate immune 
response.
absence of TnF on Myeloid and T cell 
renders Defective T-cell responses 
during cerebral Tuberculosis
To explore whether the myeloid- and T-cell-derived TNF alter 
influx of T cells into the brain, we quantified CD3+CD4+ and 
CD3+CD8+ T cell recruitment in the TNFf/f, MT-TNF−/−, and 
TNF−/− mouse brains after M. tuberculosis cerebral infection. We 
observed an overall increase in the frequencies of CD3+CD4+ 
and CD3+CD8+ T cells in the brains of all strains over 3 weeks 
postinfection, especially more in MT-TNF−/− and TNF−/− at all 
time points (data not shown). At 3 weeks postinfection, the fre-
quency of CD3+CD4+ cells in the MT-TNF−/− and TNF−/− mouse 
brains was more than twofold higher compared to TNFf/f mice 
(Figure 4A). The frequencies of CD3+CD8+ T cells in MT-TNF−/− 
and TNF−/− mice at week 3 postinfection were found more than 
threefold higher compared with TNFf/f mice. Comparatively, 
MT-TNF−/− and TNF−/− mice exhibited similar frequencies of 
CD3+CD4+ and CD3+CD8+ T cells in the brain (Figure  4A). 
When assessing the absolute cell numbers of infiltrating cells 
at 3  weeks postinfection, we found equivalent numbers of 
CD3+CD4+ (Figure 4B) and CD3+CD8+ (Figure 4C) T cells in 
the MT-TNF−/− and TNF−/− mice, which were significantly higher 
compared to TNFf/f mice. To further examine the effector func-
tion of these T cells, we analyzed the expression levels of CD44. 
The percentage of CD3+CD4+ (Figure  4D) and CD3+CD8+ 
(Figure  4E) T cells expressing CD44 in both MT-TNF−/− and 
TNF−/− mice were significantly higher (p < 0.001) than in TNFf/f 
mice at week 3 postinfection. Therefore, these data suggest that 
FigUre 1 | continued
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FigUre 2 | Myeloid cells and T-cells are important source for tumor necrosis factor (TnF)-dependent pathology during cerebral tuberculosis. 
Hematoxylin and eosin-stained coronal brain sections of TNFf/f, MT-TNF−/−, and TNF−/− mice (n = 5 mice/group) at day 21 postinfection are presented. Ventriculitis of 
the choroid plexus accompanied by necrosis (box) are observed. Corresponding Ziehl–Neelsen stain revealed acid-fast bacilli (arrows). The images are 
representatives of three to five independent experiments.
FigUre 1 | continued 
Tumor necrosis factor (TnF) produced by myeloid and T-cells is essential for protection against Mycobacterium tuberculosis infection in the brain. 
TNFf/f (black circle), MT-TNF−/− (black square) and TNF−/− (clear circle) mice were infected with M. tuberculosis H37Rv at a dose of 1 × 104–1 × 105 CFU/brain by 
intracerebral inoculation. Mortality (a) and body weight changes (B) were measured and recorded for the experimental duration (n = 5–7 mice/group). (c) Bacterial 
burdens in brains, spleens, and lungs were determined at day 14 and 21 postinfection. These data were one representative out of three to five independent 
experiments (*p ≤ 0.05, **p ≤ 0.01, and ***p ≤ 0.001).
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in the absence of myeloid and T cell-derived TNF, as well as in 
the complete ablation of TNF, the overall T cell response was 
deregulated by means of T cell influx and activation.
Differential regulation of cytokines and 
chemokines by Myeloid and T-cell-
Derived TnF during cerebral M. 
tuberculosis infection
To further dissect the mechanism behind the increased innate 
immune cell recruitment and T cell development, we analyzed 
the levels of cytokines and chemokines induction in response 
to M. tuberculosis infection. We measured concentrations of 
the cytokines, TNF, IFN-γ, IL-2, IL-6, and IL-12p70, as well as 
the chemokines, MIP-1α, MCP-1, and RANTES, in the brain 
homogenates of TNFf/f, MT-TNF−/−, and TNF−/− mice after 
3 weeks intracerebral infection (Figure 5).
As expected, no TNF production was detected in TNF−/− 
mice and the induction of TNF in TNFf/f mice confirmed its 
requirement as part of protective immune responses. TNF 
expression in MT-TNF−/− mice indicated that TNF in the 
3 weeks M. tuberculosis-infected brain were mostly contributed 
by myeloid and T cells. Similar to the reduced TNF production 
of MT-TNF−/− mice, IL-2 and IL-12p70 in MT-TNF−/− mouse 
brains were also significantly lower compared to TNFf/f mice. 
Alternatively, we observed increased levels of IFN-γ and IL-6 
production in MT-TNF−/− mice, which were significantly higher 
than the TNFf/f mice. We found similar expression levels in both 
MT-TNF−/− and TNF−/− infected brains, which were significantly 
higher (p < 0.01) than the TNFf/f-infected brains.
FigUre 3 | Tumor necrosis factor (TnF) production by myeloid cells and T-cells is required for activation and regulation of innate immunity during 
cerebral tuberculosis. TNFf/f (black), MT-TNF−/− (gray), and TNF−/− (clear) mice were infected with Mycobacterium tuberculosis H37Rv at a dose of 1 × 104–
1 × 105 CFU/brain by intracerebral inoculation. The number of (a) CD11b+CD45low microglia and (B) CD11b+CD45high macrophages and the frequency of (c,D) 
MHC II and (e,F) CD80 expression was analyzed by flow cytometry at day 21 postinfection. Data (mean ± SEM of five mice) are representative of three repeat 
experiments (*p ≤ 0.05, **p ≤ 0.01, and ***p ≤ 0.001).
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Therefore, data showed that myeloid and T cell-derived TNF 
have differential effects on cytokine and chemokine production 
during cerebral M. tuberculosis infection. These results also illus-
trate that deletion of TNF from myeloid and T cells rendered an 
uncontrolled increase of IFN-γ and IL-6 protein and reduced IL-2 
and IL-12p70 production. The results further demonstrate that 
ablation of TNF in myeloid and T cells resulted in an impaired 
chemoattractant response during cerebral M. tuberculosis 
infection.
DiscUssiOn
It has been demonstrated that elevated levels of TNF are associ-
ated with TB meningitis and tuberculoma (12, 13). More recently, 
FigUre 4 | continued
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FigUre 5 | Myeloid and T-cells-derived tumor necrosis factor (TnF) regulates synthesis of cytokine and chemokines. (a) TNF, (B) IFN-γ, (c) IL-2, (D) 
IL-6, (e) IL-12p70, (F) MIP-1α, (g) MCP-1, and (h) RANTES cerebral concentrations were measured by ELISA in TNFf/f, MT-TNF−/−, and TNF−/− mice at day 21 after 
intracerebrally infected with Mycobacterium tuberculosis H37Rv. Data (mean ± SEM of five mice) are representative of at least three repeat experiments (*p ≤ 0.05, 
**p ≤ 0.01, and ***p ≤ 0.001).
FigUre 4 | continued 
cerebral tuberculosis-induced T-cell response is dependent on the myeloid and T-cells-derived tumor necrosis factor (TnF). (a) Representative FACS 
plots of CD3+CD4+ and CD3+CD8+ cells in TNFf/f, MT-TNF−/−, and TNF−/− mice at day 21 after intracerebrally infected with Mycobacterium tuberculosis H37Rv. The 
number of (B) CD3+CD4+ and (c) CD3+CD8+, and the frequency of (D) CD4+CD44+ and (e) CD8+CD44+ expression, was analyzed by flow cytometry at day 21 
postinfection. Data (mean ± SEM of five mice) are representative of three repeat experiments (*p ≤ 0.05, **p ≤ 0.01, and ***p ≤ 0.001).
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data from human, mouse, and zebrafish indicate that a relative 
deficiency of TNF results in destructive immunopathology dur-
ing CNS-TB infection (6, 15). This study has shown that TNF 
is absolutely required for protective host immune responses 
during CNS-TB and is in agreement with the previous reports. 
In the CNS, TNF is produced by immune and non-immune cells 
(20); however, the mechanisms by which cell-specific TNF acts 
to control CNS-TB and cellular recruitment to the infection 
site are not clearly defined. In this study, MT-TNF−/− mice were 
highly susceptible to cerebral tuberculosis infection. Therefore, 
9Hsu et al. Cell-Specific TNF and CNS-TB
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we have demonstrated ablation of TNF from myeloid and T cells 
resembled complete ablation of TNF, suggesting that myeloid and 
T cells are major sources of TNF in mediating immune protec-
tion against CNS-TB. It also provides important evidence that 
synergistic activity of TNF derived from myeloid cells and T cells 
is required for optimum protection.
As part of the host–pathogen interaction, M. tuberculosis 
induces a TNF-dependent host immune response orchestrated 
from various cell types (4, 24, 31, 32). TNF signaling through 
TNF receptors (TNFRp55 and TNFRp75) forms an integral com-
ponent in protective immunity against tuberculosis (1, 30, 33). To 
dissect the cellular contribution to TNF functions, Grivennikov 
and colleagues were first to generate and report the cell-specific 
TNF-deficient mice. They used Cre-loxP recombination system 
to target TNF gene and generated TNFf/f and TNF−/− mouse 
together with a panel of cell-specific TNF-deficient mice and 
successfully demonstrated selective and efficient ablation of TNF 
in myeloid cells or/and lymphocytes of these mice by ELISA 
and intracellular TNF staining (29). The use of cell-specific 
gene-deficient mice has yielded insight into regulatory roles of 
cell type-specific expression of TNF and TNFRp55 in immune 
control during mycobacterial infection (4, 15, 29, 30). Previously, 
we have identified myeloid and lymphoid cells as critical sources 
of TNF for control of pulmonary M. tuberculosis infection; while 
myeloid TNF is required for early innate immune protection, 
T cell-derived TNF has a prominent role for chronic infection. 
Moreover, myeloid and T cell TNF act collectively in pulmonary 
tuberculosis resembling the effect of overall TNF (4). This distinct 
cellular contribution of TNF has also been seen in neuroinflam-
mation. Kruglov and colleagues have shown that myeloid and 
T cells are the critical source of TNF during EAE, where the 
MT-TNF−/− mice recapitulated the pathology and disease pro-
gression seen in complete TNF-deficient mice (19). Despite the 
different pathogenesis in EAE and CNS-TB, our current study 
suggested that myeloid cells and T cell are the main source of total 
TNF production in the brain at day 21 postinfection. Although, 
there are differences in organ-specific makeup between the brain 
and lung, the overall results of MT-TNF−/− mice in CNS-TB are 
consistent with those seen in pulmonary TB (4), indicating that 
the underlying immune protective mechanisms in both pulmo-
nary and CNS-TB model are similar.
During pulmonary M. tuberculosis infection, the innate 
myeloid cells are crucial for immune protection in a TNF/
TNFRp55-dependent manner. The absence of TNF or TNFRp55 
in macrophages and dendritic cells dramatically impaired the host 
responses to acute pulmonary M. tuberculosis infection (4, 30). In 
the CNS, microglia are considered the resident macrophages and 
shared the same myeloid origin as the peripheral monocytes dur-
ing early development; however, emerging evidence suggests that 
microglia differ considerably from the circulating macrophages 
(34, 35). Some concerns have been raised with respect to the 
use of Cre-LysM system to target gene deletion specifically in 
microglia in which Cre transgene is constitutively expressed in 
the lysozyme loci of myeloid cells. Different data were reported 
on the percentage of gene recombination/deletion in microglia 
(36–38); however, it was shown that the difference in efficiency 
of gene recombination lies in the active states of microglia (38). 
In this study, we have analyzed the numbers and the functionality 
of CD11b+CD45low and CD11b+CD45high cells; however, it is not 
within the scope of our study to differentiate the TNF contribu-
tion from resting to active microglia. We have shown the ability 
of myeloid-specific TNF-deficient mice to survive the cerebral 
M. tuberculosis infection; however, we do not discriminate the 
important role of microglia as the main source of TNF in the 
brain during CNS-TB (18, 22–24). Although we did not observe 
mortality in the MN-TNF−/− mice after cerebral M. tuberculosis 
infection, it is likely that TNF production from other cell-types 
compensate the effects (4, 18, 20). To gain more insight on TNF 
production by other cell types in the CNS, we have recently 
generated neuron-specific TNF-deficient mice (Ns-TNF−/−) to 
study the role of neuron-derived TNF in CNS-TB (15). In our 
previous report, we have demonstrated specific TNF ablation in 
the neurons of Ns-TNF−/− mouse by intracellular TNF staining 
that shows TNF production in the TNFf/f neurons, but not in the 
Ns-TNF−/− and TNF−/− neurons. While neuron-derived TNF is 
dispensable in protective immunity against CNS-TB, neurons 
contribute to TNF production during CNS-TB (15). Astrocytes 
as the most abundant glial cell population are also capable of 
secreting TNF in response to various stimuli (39–41). Although 
astrocytes have been shown to internalize M. tuberculosis bacilli 
(23), the roles of reactive astrocytes during the response to M. 
tuberculosis infection are only beginning to be elucidated.
Unlike the MN-TNF−/− mice, uncontrolled cellular recruit -
ment and poor immune activation in MT-TNF−/− mice have 
provided conclusive evidence that collective TNF production 
by myeloid and T cells is critical in immune regulation during 
CNS-TB infection. Taken together the survival of MN-TNF−/− and 
T-TNF−/− mice in CNS-TB, we also speculate the synergistic effect 
of myeloid and T cell-derived TNF in chronic infection. It has been 
demonstrated in a chimeric transfer study that both macrophage 
and T cell-derived TNF are required for sufficient and long-term 
protection against M. tuberculosis infection (26). The control of 
latent infection is TNF dependent that requires macrophage and 
T cells to form and maintain the granuloma structure (32, 42, 43). 
Infected macrophages produce TNF and induce the expression of 
chemokines, such as IL-8, MCP-1, and RANTES, which provide 
signals for migration of immune cells to the sites of M. tuberculosis 
infection (44, 45). As evident in our study, we found deregulated 
expression of chemokines in the absence of TNF expression in 
myeloid and T cells that causes a profound effect on the cellular 
recruitment.
Tumor necrosis factor is involved in both immune and immu-
nomodulatory responses and acts in synergy with T cell-derived 
IFN-γ to enhance the macrophages antimycobactericidal activity 
of nitric oxide and other RNI by iNOS. IFN-γ is mainly produced 
by T cells and natural killer cells in response to dying bacterial-
infected macrophages (46, 47); the uncontrolled increase IFN-γ 
concentrations observed in the respective mouse strains corre-
lated with the increase infiltrating of effector CD4+ and CD8+ 
T cells. A study by Flynn et al. (1) using IFN-γ−/− mice clearly 
demonstrated the important role of IFN-γ in the protective 
immune response to M. tuberculosis infection, while other studies 
using transgenic mice have shown that IFN-γ overexpression in 
the CNS increases disease progression (48, 49). Our studies that 
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show a correlation between high IFN-γ expression and advanced 
TB disease support these findings.
Besides increase production levels of IFN-γ, the cytokine IL-2 
was found to be lower in MT-TNF−/− and TNF−/− brains, yet, the 
infiltration of effector T cells was higher than in the TNFf/f mice. 
This coincides with the previous findings of dysregulated T cell 
trafficking to the brains of IL-2-deficient mice attributes to CNS 
autoimmunity (50–52). Moreover, the loss of brain IL-2 expres-
sion changes the neuroimmunological milieu such as an increase 
in concentrations of endogenous CXCL10, MCP-1, and IL-15, 
which is a potent T cell chemoattractant shares the same IL-2 
receptor subunits for signal transduction (53–55). Originally, IL-2 
described as a potent T cell growth factor is known to promote 
the proliferation and survival of effector T cells. Recent studies 
have highlighted the role of IL-2 in the regulation of immune 
responses and regulatory T cell (Treg) homeostasis where 
cytokine competition is crucial for the balance between tolerance 
and response (56–58). Tregs are a population of T cells character-
ized by the expression of CD25 (IL-2Ra) and the transcription 
factor Foxp3, and their general role has been demonstrated as 
immunosuppressive in various experimental settings of autoim-
mune diseases (59, 60). Another possibility of lower brain IL-2 
production in MT-TNF−/− and TNF−/− mice may be a direct result 
of TNF deficiency. Although the proinflammatory effects of TNF 
signaling through TNFRp55 and TNFRp75 are well documented, 
increasing evidence indicates the immunoregulatory effects of 
TNF–TNFRs on Treg cell function (59, 61, 62). The expansion 
of Tregs upon mycobacterial infection has been shown in animal 
and clinical studies (63, 64). Moreover, the accumulation of Tregs 
was found in the CNS after mycobacterial and viral infection, 
which regulates T cells trafficking to CNS (18, 65). We have previ-
ously shown a modulatory role of TNFRp75 shedding-mediated 
TNF signaling in IL-12-dependent dendritic cell migration and 
M. tuberculosis-specific T cell activation (33). Recently, it has been 
shown that TNF–TNFRp75 interaction plays a critical role in the 
expansion of Tregs (61, 66, 67). Here, we observed an increase 
in chemokine production in MT-TNF−/− mice and comparable 
to TNF−/− mice, which correlated with increased recruitment of 
infiltrating leukocytes into the brain. Therefore, it is possible in 
our study that the absence of TNF disrupts Treg function and 
causes uncontrolled T cell responses during CNS-TB infection. 
Taken together, TNF production by myeloid cell and T-cell is 
pivotal in regulating T cell immunity.
In conclusion, our data demonstrate that ablation of TNF in 
myeloid and lymphoid T cells renders the protective immunity 
ineffective, leading to increase susceptibility. In conclusion, the 
findings in this study corroborate earlier reports of the importance 
of TNF in immune-mediated responses against tuberculosis. We 
further showed that the TNF production by both myeloid cell and 
T-cell is essential for this process and the future development of 
improved diagnostic and therapeutic strategies.
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